Approval · Notice of Compliance 18956 · 2017
ODEFSEY: Notice of Compliance 18956
Issued February 10, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18956
- Date
- February 10, 2017
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ODEFSEY | 02461463 | Marketed |
Medicinal ingredients
- EMTRICITABINE 200 MG per TAB
- RILPIVIRINE HYDROCHLORIDE 25 MG per TAB
- TENOFOVIR ALAFENAMIDE FUMARATE 25 MG per TAB